Natural Alternatives International, Inc. (NAII)

From the record

Natural Alternatives International, Inc.'s filings since 2017 show 2 warning events of 2 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2021-06-09); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2026-05-18) (its current reports).

From the record

Natural Alternatives International, Inc.'s 9 filed years say what it did: revenue went from $132 million in fiscal 2018 to $143 million in fiscal 2026, up 0.9% a year; it rose in 4 of 8 years; the deepest fall was 36% from fiscal 2021 to fiscal 2024; net income was positive in 5 of 9 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2026-06-30, Natural Alternatives International, Inc. lost about 41 cents for every dollar of shareholders' money, and gross profitability: its products earned about 7 cents per dollar of everything the company owns. Leverage: it owed about 60 cents per dollar of assets, and net share issuance: its share count grew 1.4% over the year (the filed statements).

From the record

Natural Alternatives International, Inc.'s standing among 18 graded names in its industry family: revenue of $143 million in fiscal 2026 ranks in the top 46% by size; a net margin of -14.5% ranks in the bottom 36%; revenue growth of -2.6% a year over the last 3 filed years ranks in the bottom 25% (its annual reports).

From the record

Natural Alternatives International, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Ledoux, Mark A (CEO/Chairman, as filed), filing under that title since 2006-01-10, 20.8 years (top 5% of its family); the 6 officers and directors filing in the last fifteen months have been on the record a median of 14.9 years (top 5%); 3 officer or director changes were reported on Form 8-K since 2023-11-13, against the 6 people in charge now (top 42%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Natural Alternatives International, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $7 million against no long-term debt tagged leaves 5.8% of its assets as net cash, bottom 39% of its family; cash from operations less capital spending is -8.9% of revenue (bottom 19%); a gross margin of 6.3% (bottom 3%); research spending of 1.6% of revenue (top 41%) (its annual report).

From the record

Natural Alternatives International, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew -2.6% a year over the last three filed years against 0.9% over all 9, slowing (top 31% of its family); the newest year grew 9.8% (top 36%); research spending grew 3.1% a year (top 29%); capital spending grew -35.1% a year (bottom 21%) (its annual reports). Natural Alternatives International, Inc. reported 2 lines of business in fiscal 2025: Private Label Contract Manufacturing at $122 million, Patent and Trademark Licensing at $8 million. 1 of 2 grew in the latest filed year, and the largest line is 94% of revenue (its annual report).

From the record

Natural Alternatives International, Inc.'s newest year against its own record: revenue of $143 million in fiscal 2026 came in 19.5% above the $119 million its prior three years' pace pointed to (top 8% of its family); net income of $21 million against a prior three-year average of $6 million (bottom 14%); a net margin of -14.5% against -5.1% before (bottom 25%) (its annual reports).